However, according to the bidirectional MR analysis, ACP5, CPB2, GSTM3, NTNG1 and FMA171B obtained reliable changes when SCLC occurred, indicating their capabilities as biomarkers for SCLC. The gene discussed is CPB2; the disease is small cell lung carcinoma.